Electroconvulsive Therapy Administration

Obtaining informed consent
The patient is informed about the benefits and risks of the therapy before they provide their consent that the procedure goes ahead. The doctor treating the patient is under a legal obligation to ensure that the patient is informed of the following points prior to treatment with ECT:

  • The reason for the treatment
  • The risks associated with ECT
  • The treatment plan
  • The risks and benefits of alternative treatments at the stage of disease concerned
  • The risks and benefits of not receiving any ECT therapy versus receiving therapy

Once these facts are explained, the patient is given the opportunity to reject or accept the treatment. At any time during the course of the treatment plan, the patient retains the right to refuse the treatment and revoke his or her informed consent.

Prior to treatment
Before treatment, the patient is administered a short-acting anesthetic to render them unconscious. Examples of the anesthetics used include methohexital, etomidate and thiopental. A muscle relaxant such as succinylcholine may also be used and sometimes atropine is administered to prevent salivation.

Electrode placement
For unilateral ECT, two electrodes are placed on one side of the patient’s head. The unilateral therapy may be used initially, to limit memory loss. When electrodes are placed on either side of the head, the therapy is called bilateral ECT. Patients in the UK usually receive bilateral ECT.

The ECT treatment
The electrodes deliver an electrical stimulus to the brain that is over the individual’s seizure threshold, usually about one and a half times the threshold in the case of bilateral ECT and up to 12 times the threshold when unilateral ECT is used.

The patient’s blood oxygen level, ECG and EEG are carefully monitored throughout the therapy.

Further Reading

Last Updated: Feb 26, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 26). Electroconvulsive Therapy Administration. News-Medical. Retrieved on January 31, 2023 from https://www.news-medical.net/health/Electroconvulsive-Therapy-Administration.aspx.

  • MLA

    Mandal, Ananya. "Electroconvulsive Therapy Administration". News-Medical. 31 January 2023. <https://www.news-medical.net/health/Electroconvulsive-Therapy-Administration.aspx>.

  • Chicago

    Mandal, Ananya. "Electroconvulsive Therapy Administration". News-Medical. https://www.news-medical.net/health/Electroconvulsive-Therapy-Administration.aspx. (accessed January 31, 2023).

  • Harvard

    Mandal, Ananya. 2019. Electroconvulsive Therapy Administration. News-Medical, viewed 31 January 2023, https://www.news-medical.net/health/Electroconvulsive-Therapy-Administration.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment